Part of the expanding PassProfessor catalog: This program is built — 1,500 original practice questions, weighted to NABP’s current MPJE Competency Statements — and it opens for enrollment soon as part of the expanding PassProfessor catalog. Join the notify list and we will email you when enrollment opens.
This program is part of the expanding PassProfessor catalog — join the notify list and we’ll email you when enrollment opens.
The Louisiana MPJE is NABP’s Multistate Pharmacy Jurisprudence Examination as administered for Louisiana pharmacist licensure: 120 questions in 2.5 hours at Pearson VUE — 100 scored plus 20 unscored pretest — mixing federal and Louisiana law with no distinction between them, reported pass/fail. PassProfessor’s Louisiana MPJE program, part of the expanding PassProfessor catalog, holds 1,500 original practice questions — an 800-question federal core intermixed with 700 Louisiana questions — weighted to NABP’s current Competency Statements, priced at $49, and opening for enrollment soon.
What is included in the Louisiana MPJE program?
A bank built the way the exam is built. The MPJE makes no distinction between federal and state questions, so neither does this bank: 800 federal-core questions and 700 Louisiana questions are intermixed in a single 1,500-question bank, and where a Louisiana rule differs from the federal rule, the Louisiana rule keys the answer — the same instruction NABP gives on the exam itself.
An explanation on every question. Every one of the 1,500 questions carries an explanation of why the keyed answer is right. Jurisprudence is a subject where the tempting wrong answer is usually the other jurisdiction’s rule or the federal default, and the explanation names the distinction instead of leaving you to guess at it.
Practice exams at the real exam’s shape. A full practice exam draws 100 scored questions — the scored length of the real exam — across the four competency areas at their published weights, inside the real 150-minute clock. Draws are generated fresh for each attempt, questions you have not seen come first, and you never sit the same generated exam twice. Practice exams are scored against a 70% practice benchmark — a preparation target only, because the real MPJE reports pass/fail and NABP publishes no raw passing score.
Drills by competency area. Work one area at a time — Licensure and Personnel, Pharmacist Practice, Dispensing Requirements, or Pharmacy Operations — and your results break down by area, so a weak area shows up in your practice data before it shows up on a score report.
The real exam at a glance
Current as of November 2026, per NABP’s MPJE program pages and Competency Statements and Louisiana Board of Pharmacy. Full detail — eligibility, application steps, retakes, test day — is in our Louisiana MPJE exam guide.
| Exam fact | Louisiana MPJE |
|---|---|
| Questions administered | 120 (100 scored + 20 unscored pretest, mixed in) |
| Time limit | 2.5 hours (150 minutes) |
| Format | Computer-based, multiple choice, at Pearson VUE |
| Federal vs. state questions | Intermixed with no distinction; each question is answered under the prevailing law of Louisiana |
| Scoring | Pass/fail. NABP does not publish a raw passing score, and no percentage of correct answers is the passing standard |
| Passing score | No numeric passing score is published for this exam — the result is reported as pass or fail |
| Attempts | Up to 5 per jurisdiction |
| Fees | About $270 per attempt in NABP fees |
| Eligibility | Confirmed by NABP (Louisiana is one of the jurisdictions for which NABP confirms eligibility) |
| Score transfer | MPJE scores are not transferable between jurisdictions — a Louisiana result applies to Louisiana licensure only |
How does the practice map to the real exam?
| NABP competency area | Share of the real exam | Practice questions in this program | Questions per full practice exam |
|---|---|---|---|
| Area 1 — Licensure and Personnel | 22% | 333 | 22 |
| Area 2 — Pharmacist Practice | 33% | 498 | 33 |
| Area 3 — Dispensing Requirements | 24% | 358 | 24 |
| Area 4 — Pharmacy Operations | 21% | 311 | 21 |
The federal half of every MPJE is the same body of law, and it is larger than most candidates expect. The shared 800-question federal core in this program covers the Controlled Substances Act framework end to end: the five schedules, the rule that Schedule II prescriptions never refill, the five-refills-in-six-months limit for Schedules III and IV, emergency oral Schedule II orders and the prescriber’s seven-day follow-up duty, partial fills, pharmacist-to-pharmacist transfers of Schedules III–V, DEA registration and Form 222/CSOS ordering, biennial inventories, theft and loss reporting, and disposal. It covers the Food, Drug, and Cosmetic Act in the form the exam tests it — adulteration versus misbranding, generic substitution and Orange Book equivalence, container labeling, child-resistant packaging, Medication Guides and REMS programs, the three recall classes, expiration and beyond-use dating, DSCSA track-and-trace duties, and the line between 503A patient-specific compounding and 503B outsourcing facilities. It covers OBRA ’90 prospective drug review and counseling duties, USP <795>, <797> and <800> compounding standards, HIPAA’s treatment/payment/operations framework and breach-notification duties, and the personnel principles that hold in every state: the pharmacist-in-charge answers for the pharmacy’s compliance, technicians never counsel, and no dispensing happens when no pharmacist is on duty.
What Louisiana law does the exam test?
Half of what makes the Louisiana MPJE hard is that it is two bodies of law at once. The Louisiana half of this program is built on:
The Louisiana questions in this bank are grounded in primary Louisiana sources read first-hand: the Pharmacy Practice Act (Louisiana Revised Statutes Title 37, Chapter 14), the Board of Pharmacy regulations (Louisiana Administrative Code Title 46, Part LIII), the Uniform Controlled Dangerous Substances Law (Revised Statutes Title 40, Chapter 4) and the Prescription Monitoring Program Act (Title 40, Chapter 4, Part X-A), and the 2024 through 2026 session laws. Louisiana’s rulebook has moved recently: the controlled-substances chapter of the Board’s regulations was rewritten effective May 20, 2026, and the state-specific rules that used to sit in the older sections — prescription expirations, the annual controlled-substance inventory, theft-and-loss reporting — now live in a single section, LAC 46:LIII.2713. This bank keys on current law throughout, including the 2026 changes.
Louisiana’s prescription monitoring program is the PMP — and in Louisiana the familiar name trap does not fire, because the name is defined in the statute itself: ‘Prescription monitoring program’ and ‘PMP’ are defined terms at R.S. 40:1003(14), in the Prescription Monitoring Program Act (R.S. 40:1001–1014). The Act also defines ‘Board’ — it means the Louisiana Board of Pharmacy, which establishes and maintains the program. The Department of Health does not administer the PMP (it holds the separate authority to schedule substances), and the program’s software vendor is not its administrator. The reporting duty falls on the dispenser, and it is fast: no later than the next business day after dispensing, for Schedule II, III, IV and V controlled substances and for drugs of concern — the seven-day and weekly figures in older study materials are superseded law. Louisiana’s mandatory look-up duty is narrow and sits on the prescriber: before initially prescribing an opioid, and at least every 90 days during continuing opioid treatment, under R.S. 40:978(F)(1); no equivalent look-up mandate falls on the dispensing pharmacist. Gabapentin appears on the Board’s current list of drugs of concern reported to the program, even though it is not a scheduled drug in Louisiana. PMP data are confidential — knowingly obtaining, using or disclosing them unlawfully carries up to five years in prison or a $5,000 fine — and the program’s annual fee is capped at $25, leviable only if the legislature does not fully fund the program.
Louisiana’s controlled-substance rules split between two agencies and carry their own numbers. The CDS license is issued by the Board of Pharmacy — including to third-party logistics providers — while the authority to place substances in the schedules belongs to the secretary of the Department of Health; neither function belongs to the other agency. Louisiana’s schedule choices diverge from the federal list in both directions: carisoprodol is Schedule II in Louisiana though it is Schedule IV federally; kratom is Schedule I and fully banned; and mifepristone and misoprostol are Schedule IV controlled substances here though they are not federally controlled at all — while gabapentin is not scheduled anywhere in Louisiana law. Since the May 2026 rewrite, a Schedule II prescription expires 90 days after the date it was issued, Schedule III and IV prescriptions expire at six months, and Schedule V at one year. Opioid rules reward close reading: a first prescription for acute pain in an adult, and any opioid prescription for a minor, is capped at a seven-day supply under R.S. 40:978(G) — and Louisiana has no morphine-milligram-equivalent threshold anywhere in the statute, so MME caps borrowed from other states’ rules are traps, not law. Electronic prescribing of controlled substances is permitted in conformance with the federal rules; Louisiana imposes no state e-prescribing mandate of its own. And an opioid-derivative Schedule II or III prescription written by an out-of-state prescriber may be dispensed for no more than a ten-day supply, with no further dispensing for sixty days.
Substitution in Louisiana runs on patient consent, not on a formulary. There is no standalone substitution statute and no Louisiana state or negative formulary: interchange is governed by an unprofessional-conduct standard under which the pharmacist must inform the patient of the equivalent product and its approximate cost difference and obtain the patient’s consent. The Medicaid prescriber bar works the other way from most states — the prescriber handwrites ‘brand medically necessary’ or ‘brand necessary’ on the prescription. After dispensing an interchangeable biological product, the pharmacist must communicate the specific product dispensed to the prescriber no later than five business days after dispensing. Refill emergencies run on Louisiana numbers, not the familiar federal ones: an ordinary emergency refill may run to a thirty-day supply, and during a governor-declared emergency a pharmacist may dispense up to a ninety-day supply without prescriber authorization, a power that activates automatically with the declaration — no seventy-two-hour figure exists in either Louisiana rule. Pharmacists alone administer immunizations in Louisiana: influenza vaccine from age seven, and all other vaccines from age seventeen. Pseudoephedrine sales are capped at nine grams per thirty days, reported in real time to the central monitoring system administered by the Louisiana State Police.
The people rules run on their own calendars. The Board of Pharmacy has seventeen members — two licensed pharmacists from each of the state’s eight pharmacy districts plus one consumer representative serving at large — and pharmacist members serve six-year terms. Aspiring pharmacists complete 1,740 internship hours, at least 1,500 of them practical; licensure begins at age twenty-one; and examination scores expire one year after the examination. A pharmacist-in-charge needs one year of experience. Continuing education is fifteen hours a year, including at least three live hours — or twenty hours in total if the live hours are not completed. Pharmacist licenses and pharmacy permits expire December 31 each year, while pharmacy technician certificates expire June 30. Under Louisiana’s license-transfer rules, the MPJE-La must be passed before the NABP license-transfer application can be completed, and no practice-recency requirement attaches to transfer. And Louisiana law states no numeric passing score for its examinations: the standard is a passing score, as determined by the Board, on examinations administered by NABP.
What changes on March 1, 2027?
From March 1, 2027, NABP replaces the MPJE Competency Statements with a new Content Outline: Pharmacy and Pharmacist Practice 30%, Medication Use Process 30%, Regulatory Authority and Legal Obligations 20%, and Pharmacy Operations 20%. Every question in this bank is dual-tagged to both blueprints, so the program’s practice exams re-weight to the new outline when the change takes effect — the questions you practice stay the right questions, at the new weights. Candidates testing before March 1, 2027 prepare against the current Competency Statements, which is how the bank is weighted today.
How should you use this program?
Work the bank in three passes. First, take a full 100-question practice exam under the 150-minute clock to find your baseline — the per-area results show exactly where the points are being lost. Second, drill the weakest competency area in focused sets, reading the explanation for every item, right or wrong: each explanation states why the keyed answer is right, so a wrong drill answer becomes a rule learned rather than a guess missed. Third, return to full practice exams drawn fresh from the bank — questions you have not seen come first, so a rising score reflects broader coverage rather than memorized items. In the final week, shift the drill mix toward Louisiana law: it is the half of the exam that no national review book teaches, and it is where candidates who prepared generically lose the most ground.
What does the program cost?
The Louisiana MPJE program is $49 for the full bank — all 1,500 questions, full-length practice exams, and per-area drills. Enrollment opens soon; join the notify list and we will email you when it opens.
Frequently asked questions
How many questions are on the Louisiana MPJE?
The exam administers 120 questions in 2.5 hours: 100 scored questions and 20 unscored pretest questions mixed in so they cannot be told apart. Your result rests on the 100 scored questions.
What score do you need to pass the Louisiana MPJE?
The MPJE is reported pass/fail against NABP’s passing standard. NABP does not publish a raw passing score, so no percentage — including the 70% benchmark this program uses in practice — is the passing standard. Older guides that quote a numeric scaled threshold describe how the exam used to be reported, not how it is reported now.
Can an MPJE score transfer to another state?
No. MPJE scores are not transferable between jurisdictions. A pass for Louisiana supports Louisiana licensure only; licensing in another MPJE state means that state’s MPJE as well. (Score transfer belongs to the separate Uniform MPJE used in other jurisdictions.)
How many times can you take the Louisiana MPJE?
Up to 5 attempts per jurisdiction. NABP fees run about $270 per attempt, so preparation before the first sitting is the less expensive route.
Who confirms eligibility for the Louisiana MPJE?
Eligibility is confirmed by NABP (Louisiana is one of the jurisdictions for which NABP confirms eligibility). You apply through NABP’s e-Profile, and eligibility must be confirmed before you can schedule at Pearson VUE.
Does the exam separate federal questions from Louisiana questions?
No — NABP states that no distinction is made in the examination between federal and state jurisprudence questions, and each question is answered under the prevailing law of Louisiana. Where the Louisiana rule and the federal rule differ, the Louisiana rule decides.
What does this program cover?
1,500 original practice questions: an 800-question federal core (controlled substances, FDA and dispensing law, compounding, privacy, licensure principles) intermixed with 700 questions on Louisiana pharmacy law, weighted to NABP’s four competency areas at 22/33/24/21 percent.
Does every question really have an explanation?
Yes — all 1,500 questions in this bank carry an explanation of why the keyed answer is right, verified from the bank files when this page was built.
What happens to my preparation when the blueprint changes in March 2027?
Nothing is lost. Every question is dual-tagged to the current Competency Statements and to the March 1, 2027 Content Outline, and the program re-weights its practice exams to the new outline — 30/30/20/20 — when the change takes effect.
Is this program affiliated with NABP or Louisiana Board of Pharmacy?
No. PassProfessor is an independent exam-preparation provider and is not affiliated with NABP, Pearson VUE, or Louisiana Board of Pharmacy. The program provides practice questions for preparation; it is not a licensure requirement and confers no eligibility.
When can you enroll?
The program opens for enrollment soon at $49. Join the notify list on this page and we will email you when enrollment opens.
Disclaimer
PassProfessor is an independent exam-preparation provider, based in Salt Lake City, Utah and delivered entirely online. It is not affiliated with NABP, Pearson VUE, or Louisiana Board of Pharmacy, and this program is preparation only — it is not pre-licensing education, confers no eligibility, and does not replace the official sources. Exam facts on this page are stated as of November 2026 from NABP and Louisiana primary sources; confirm current requirements with NABP and Louisiana Board of Pharmacy before you apply.
—